You are here

Article info

Article menu
Download PDFPDF
Experimental Therapeutics – Preclinical
L16 Identifying a therapeutic regimen for cholesterol delivery to huntington’s disease brain

Authors

  • Eleonora Di Paolo 1Department of BioSciences, Università degli Studi di Milano and INGM, Istituto Nazionale di Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, Italy PubMed articlesGoogle scholar articles
  • Marta Valenza 1Department of BioSciences, Università degli Studi di Milano and INGM, Istituto Nazionale di Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, Italy PubMed articlesGoogle scholar articles
  • Jane Y Chen 2Intellectual and Developmental Disabilities Research Centre, Semel Institute for Neuroscience Brain Research Institute David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, USA PubMed articlesGoogle scholar articles
  • Barbara Ruozi 3Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy PubMed articlesGoogle scholar articles
  • Daniela Belletti 3Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy PubMed articlesGoogle scholar articles
  • Carlos Cepeda 2Intellectual and Developmental Disabilities Research Centre, Semel Institute for Neuroscience Brain Research Institute David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, USA PubMed articlesGoogle scholar articles
  • Laura Colombo 4Department of Molecular Biochemistry and Pharmacology, IRCCS, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy PubMed articlesGoogle scholar articles
  • Luisa Diomede 4Department of Molecular Biochemistry and Pharmacology, IRCCS, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy PubMed articlesGoogle scholar articles
  • Alfredo Cagnotto 4Department of Molecular Biochemistry and Pharmacology, IRCCS, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy PubMed articlesGoogle scholar articles
  • Mario Salmona 4Department of Molecular Biochemistry and Pharmacology, IRCCS, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy PubMed articlesGoogle scholar articles
  • Michael S Levine 2Intellectual and Developmental Disabilities Research Centre, Semel Institute for Neuroscience Brain Research Institute David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, USA PubMed articlesGoogle scholar articles
  • Giovanni Tosi 3Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy PubMed articlesGoogle scholar articles
  • Elena Cattaneo 1Department of BioSciences, Università degli Studi di Milano and INGM, Istituto Nazionale di Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, Italy PubMed articlesGoogle scholar articles

Citation

Paolo ED, Valenza M, Chen JY, et al
L16 Identifying a therapeutic regimen for cholesterol delivery to huntington’s disease brain
Journal of Neurology, Neurosurgery & Psychiatry 2016;87:A95.

Publication history

  • First published September 13, 2016.
Online issue publication 
September 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions